Virogentics: Pioneering Immunity Enhancement

Virogentics: Pioneering Immunity Enhancement
Image Internally Provided

In a world where the importance of a robust immune system has never been more apparent, Virogentics takes center stage with its groundbreaking product, IPF Immune®. This liquid nutritional dietary supplement is not just another addition to the crowded health and wellness market; it’s a game-changer. As their special quote suggests, “Boost Your Immunity, Boost Your Life,” Virogentics is on a mission to empower individuals to live healthier lives by offering scientifically innovative products in nutrition.

At the heart of Virogentics’ mission is IPF Immune®, a one-of-a-kind immune-enhancing supplement. What sets this product apart from the competition is its unique formulation, which incorporates an Irreversibly inactivated Pepsin fragment. This groundbreaking ingredient, exclusive to IPF Immune®, has been proven to fortify the immune system against infections.

IPF Immune® is not just about boosting immunity; it’s about doing it safely. Unlike some widely-used antiviral medications like Acyclovir (used for treating Herpes) and Tamiflu (used for Influenza), which have been found to be 35 times more toxic to the body, IPF Immune® delivers similar benefits without the associated risks.

This innovative supplement is registered under NDI #1083, and it boasts Patent #8,309,072. This patent covers the utilization of the Irreversibly inactivated Pepsin fragment, highlighting its significant potential as an immune supplement.

IPF Immune® offers a range of benefits for those seeking to support their immune system and maintain a healthy body. Whether you’re looking to enhance your natural defenses, protect against infections, or promote overall health, this dietary supplement can be a valuable addition to your wellness regimen.

The product’s liquid form is not only convenient but also allows for faster absorption, ensuring that your body gets the support it needs when it matters most. With IPF Immune®, individuals can stay proactive in safeguarding their health.

Virogentics’ remarkable journey and commitment to innovation are guided by its visionary founders, Diana Zhabilov and Harry Zhabilov.

Diana Zhabilov, the CEO and co-founder of Virogentics, brings a wealth of knowledge and experience to the table. With a master’s degree in nursing from the Medical Academy Sofia, Bulgaria, Diana has specialized in Pediatrics and Neonatology. Her extensive background in nursing, including education, has played a pivotal role in the development and promotion of the IPF Immune® platform, aimed at bringing this nutritional supplement to the market.

Harry Zhabilov, the CSO and co-founder of Virogentics, is a distinguished figure in the field of science and research. He is also the President and Chief Scientific Officer at Immunotech Laboratories, Inc., and a member of esteemed organizations such as the American Institute of Chemical Engineers and the American Chemical Society. Mr. Zhabilov’s impressive career includes roles as Executive Vice President at VG Life Sciences, Inc., Vice Chairman, Secretary, and Chief Science Officer at International Technology Systems, Inc., and Research Scientist at the Bulgarian Academy of the Sciences.

With a master’s degree from the University of Chemical Technology and Metallurgy in Sofia, Bulgaria, Mr. Zhabilov’s expertise extends to protein isolation and purification in immunochemistry and biochemistry, as well as therapeutic proteins used in the treatment of HIV and cancer. His contributions to several U.S. patents, related to technology for the immunotherapy of HIV and cancer, have solidified his position as a pioneering figure in the field of immunology.

Mr. Zhabilov’s extensive experience also includes the preparation of applications for nutraceutical compounds and supplements submitted to the FDA, and he is the inventor behind an immune enhancer based on the IPF (Inactivated Pepsin Fragment) platform. He has actively participated in the management of several clinical trials involving therapeutic proteins, further highlighting his dedication to advancing the field of immunotherapy.

In a time when the importance of immunity is paramount, Virogentics stands out with its groundbreaking product, IPF Immune®. With its unique formulation, safety profile, and the dedication of its visionary founders, Diana Zhabilov and Harry Zhabilov, Virogentics is making significant strides in offering scientifically innovative products in nutrition.

For those seeking a safer and more effective way to boost their immunity and live healthier lives, Virogentics’ IPF Immune® provides a promising solution. It’s not just a dietary supplement; it’s a game-changer in the pursuit of a healthier, more immune-resilient future.


This article features branded content from a third party. Opinions in this article do not reflect the opinions and beliefs of CEO Weekly.